US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

59.56

+0.08390.14%

Post-market: 59.47-0.0839-0.14%16:10 EDT

Volume:46

Turnover:3K

Market Cap:8.93M

PE:- -

High:59.56

Open:59.47

Low:59.56

Close:59.47

52wk High:64.69

52wk Low:53.59

Shares:150.00K

Float Shares:150.00K

Volume Ratio:0.55

T/O Rate:0.03%

Dividend:0.51

Dividend Rate:0.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Caplyta® (Lumateperone) Shows Significant and Rapid Improvement in Bipolar Mania in Pivotal Phase 3 Study

THOMSON REUTERS

J&J - Caplyta Well-Tolerated; Dry Mouth and Nausea Most Common Adverse Events

THOMSON REUTERS

Adarx Pharmaceuticals: IPO Price Expected Between $15 and $17 Per Share

Oura Files for Initial Public Offering on Nasdaq

MT Newswires Live

Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial

LIVE Markets-Big Beauty Faces Growing Threat from AI, Smaller Rivals

ADARx Pharmaceuticals to Sell 21.9 Million Shares at $15-$17 Each in IPO

Smart Ring Maker Oura Eyes $15.6 Billion IPO Valuation in Fall Listings Demand Test

Immunome initiated with a Buy at Alliance Global

Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing

THOMSON REUTERS

Japan Health Ministry Approves Merck’s Keytruda QLEX for Subcutaneous Use Across Keytruda Indications

Merck’s Keytruda Qlex™ (Pembrolizumab and Berahyaluronidase Alfa-Pmph) Approved in Japan for Subcutaneous Administration for All Keytruda® (Pembrolizumab) Indications Approved in Japan

THOMSON REUTERS

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Drug Developer ADARx Seeks $1.74 Billion Valuation in US IPO

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)

Prescient Therapeutics Requests Trading Halt Ahead of Capital Raising Announcement

Eli Lilly, Novo sued over risk of sudden vision loss, WSJ reports

Lilly, Novo face lawsuits over GLP-1 vision loss risk, WSJ says

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/JDOC/news?page=17"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"JDOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JDOC\",,,,,undefined,":{"symbol":"JDOC","market":"US","secType":"STK","nameCN":"JPMORGAN HEALTHCARE LEADERS ETF","latestPrice":59.5572,"timestamp":1790971200000,"preClose":59.4733,"halted":0,"volume":46,"hourTrading":{"tag":"盘后","latestPrice":59.4733,"preClose":59.5572,"latestTime":"16:10 EDT","volume":6,"amount":357.3432,"timestamp":1790971804829,"change":-0.0839,"changeRate":-0.001409,"amplitude":0},"delay":0,"changeRate":0.0014107170780837763,"floatShares":150000,"shares":150000,"eps":0,"marketStatus":"Market Closed","change":0.0839,"latestTime":"10-02 16:00:00 EDT","open":59.4733,"high":59.5572,"low":59.5572,"amount":2744,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":59.4733,"sharesOutstanding":150000,"nav":59.41,"aum":8911980.64,"dividendRate":0.008635,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":59.4733,"preClose":59.5572,"latestTime":"16:10 EDT","volume":6,"amount":357.3432,"timestamp":1790971804829,"change":-0.0839,"changeRate":-0.001409,"amplitude":0},"volumeRatio":0.546319392806375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JDOC\",,,,,undefined,":{"symbol":"JDOC","floatShares":150000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.546319392806375,"shares":150000,"dividePrice":0.5143,"high":59.5572,"amplitude":0,"preClose":59.4733,"low":59.5572,"week52Low":53.59,"pbRate":"--","week52High":64.69,"institutionHeld":0,"latestPrice":59.5572,"eps":0,"divideRate":0.008635,"volume":46,"delay":0,"ttmEps":0,"open":59.4733,"prevYearClose":57.9058,"prevWeekClose":61.3462,"prevMonthClose":60.5045,"prevQuarterClose":60.5045,"fiveDayClose":61.3462,"twentyDayClose":63.6192,"sixtyDayClose":61.4086},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JDOC\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"JDOC","amount":0.5121,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-18","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-18"},{"date":"2024-12-24","symbol":"JDOC","amount":0.3276,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-27"},{"date":"2024-12-16","symbol":"JDOC","amount":2.48902,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-18"},{"date":"2023-12-19","symbol":"JDOC","amount":0.07965,"announcedDate":"2023-12-18","type":"dividend","market":"US","newRecordDate":"2023-12-20","defaultRemindTime":1702996200000,"name":"JPMORGAN HEALTHCARE LEADERS ETF","recordDate":"2023-12-22","payableDate":"2023-12-20","currency":"USD","dateTimestamp":1702962000000,"payDate":"2023-12-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JDOC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-19","recordDate":"2023-12-20","paymentDate":"2023-12-22","value":0.07965,"currency":"USD"},{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-18","value":2.48902,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-27","value":0.3276,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-18","value":0.5121,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JDOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JDOC\",pageSize:20,pageCount:17,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669163800","title":"Caplyta® (Lumateperone) Shows Significant and Rapid Improvement in Bipolar Mania in Pivotal Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163800?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","LU0345770993.USD","IE0002141913.USD","IHE","LU1267930813.SGD","LU0210536198.USD","LU2756315664.SGD","LU1674673428.USD","FTXH","LU0820561818.USD","IXJ","BMED","JDOC","LU2471134796.USD","LU0234570918.USD","GDOC","TRUH","LU0289961442.SGD","LU0795875169.SGD","LU0689472784.USD","BK4550","VHT","LU2487616109.SGD","IYH","LU0070217475.USD","LU0289739343.SGD","LU0466842654.USD","IE000F7OJYX1.SGD","LU1059921491.USD","FHLC","IE00BJJMRZ35.SGD","BK4588","PJP","LU2129689431.USD","LU2347655156.SGD","RXL","LU0820562030.AUD","XLV","LU0345769128.USD","JNJ","BK4504","IE00B4R5TH58.HKD","LU2403377893.USD","LU1061106388.HKD","LU0994945656.USD","LU1043141123.HKD","IE0009355771.USD","LU2471134523.USD","LU0114720955.EUR","SGXZ80539844.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163385","title":"J&J - Caplyta Well-Tolerated; Dry Mouth and Nausea Most Common Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163385","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163385?lang=en_us&edition=fundamental","pubTime":"2026-09-21 20:00","pubTimestamp":1789992004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IYH","FTXH","IE00BFXG1179.USD","LU1629891620.HKD","XLV","LU2213496289.HKD","IE00BVYPNV92.GBP","LU0426417589.USD","IE00B3T34201.USD","LU0640476718.USD","LU0472753341.HKD","BK4588","LU0689626769.HKD","LU1043141123.HKD","IE00BN8TJ469.HKD","FHLC","IE00B42XCP33.USD","LU1121112475.USD","LU1894683264.USD","LU0210528500.USD","LU0124676726.USD","IXJ","LU1989771016.USD","LU2403377893.USD","JNJ","PJP","MEDX","SG9999002232.USD","LU0820562030.AUD","VHT","IE0034235303.USD","LU2468319806.SGD","IE000F7OJYX1.SGD","LU0345769128.USD","TRUH","LU2592432038.USD","BK4585","LU1551013342.USD","LU0122379950.USD","LU0545562505.USD","IHE","GDOC","JDOC","RXL","LU1280957306.USD","IE000SO60NU8.SGD","LU2471134796.USD","BMED","LU1221951129.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669163831","title":"Adarx Pharmaceuticals: IPO Price Expected Between $15 and $17 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2669163831","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669163831?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:58","pubTimestamp":1789991885,"startTime":"0","endTime":"0","summary":"BRIEF-Adarx Pharmaceuticals: IPO Price Expected Between $15 And $17 Per ShareSept 21 -AbbVie Inc.ABBV.N:ADARX PHARMACEUTICALS - IPO PRICE EXPECTED BETWEEN $15 AND $17 PER SHARE - SEC FILINGADARX PHARMACEUTICALS - TO OFFER 21,875,000 SHARES IN IPO - SEC FILINGADARX PHARMACEUTICALS - ABBVIE TO PURCHASE 5,007,844 SHARES BASED ON IPO SIZE - SEC FILINGSource text: [ID:n0001193125-26-396007]Further company coverage:ABBV.N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45A0R5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","VHT","XLV","LU1093756168.USD","LU0965509283.SGD","LU1244550577.SGD","BK4534","PPH","AGNG","LU0795875169.SGD","LU1061106388.HKD","IE0004445239.USD","FHLC","TRUH","LU1003077747.HKD","LU0158827948.USD","LU0320765646.SGD","LU1720051108.HKD","MEDX","LU1236620834.HKD","LU1732799900.SGD","GLAM","LU1934455277.USD","LU0289739699.SGD","IYH","IE000BZT7R73.USD","LU1093756325.SGD","LU2347655073.USD","JDOC","LU1023059063.AUD","LU0122379950.USD","LU0432979614.USD","LU1732800096.USD","IE00B19Z3581.USD","RXL","PJP","LU0211327993.USD","LU1236620750.USD","ABBV","LU0203347892.USD","LU0882574055.USD","LU0912757837.SGD","LU1057294990.SGD","LU2357305700.SGD","IE000SO60NU8.SGD","IE00B4R5TH58.HKD","IXJ","LU1551013342.USD","FTXH","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168714","title":"Oura Files for Initial Public Offering on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168714","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168714?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:48","pubTimestamp":1789991318,"startTime":"0","endTime":"0","summary":"Oura and some of its shareholders plan to offer 50 million common shares at an estimated price of $40 to $44 per share in an initial public offering, the smart ring maker said Monday in a Form S-1 filing.Oura is offering 13.5 million shares, while selling shareholders are offering 36.5 million shares. The underwriters have an option to purchase up to an additional 7.5 million shares from the selling shareholders.The company expects to have 320.9 million shares outstanding immediately after the offering, it said. Oura has applied to list on the Nasdaq Global Select Market under the ticker \"OURA.\"Oura estimates net proceeds of approximately $532.6 million, based on an assumed IPO price of $42 per share.The company plans to use around $526.4 million of the proceeds to cover expected tax withholding and remittance obligations associated with the net settlement of restricted stock units.The remainder will fund general corporate purposes, including technology development, working capital, op","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","LU0345770993.USD","SGXZ81514606.USD","LU0345770308.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","LU2111349929.HKD","OURA","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","XLV","IE00BJLML261.HKD","SG9999017495.SGD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669684681","title":"Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669684681","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669684681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:27","pubTimestamp":1789990051,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has shared an announcement. Tiziana Life Sciences Ltd, a clinical-stage biotechnology company specializing in imm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","BBC","FWD","IBB","RSPH","IEIH","BBP","DARP","JDOC","XT","LNGR","BK4585","AGNG","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150072","title":"LIVE Markets-Big Beauty Faces Growing Threat from AI, Smaller Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150072?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:19","pubTimestamp":1789989597,"startTime":"0","endTime":"0","summary":"LIVE MARKETS-Big Beauty faces growing threat from AI, smaller rivalsAdds blog postSTOXX 600 up 1.1%, tech leads, up 2.2%Wall St futures climbFunds cut bearish bets on Japan's yen in latest weekWelcome","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0PF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","FTXH","IE000M9KFDE8.USD","LU1121112475.USD","RXL","LU0912757837.SGD","LU0985320562.USD","LU0738911758.USD","LU1261432733.SGD","LU1732800096.USD","GLAM","FHLC","LU2602419157.SGD","LU0553294199.USD","GDOC","LU0162691827.USD","BMED","IE00BN8TJ469.HKD","IE0002270589.USD","LU0820561909.HKD","LU0949170772.SGD","BK4533","LU0795875086.SGD","LU1066051225.USD","LU2471134952.CNY","LU0943347566.SGD","IXJ","LU1629891620.HKD","LU0640476718.USD","LU0690374615.EUR","MEDX","IE00BLSP4239.USD","LU1674673428.USD","JDOC","LU1551013425.SGD","LU2430703178.SGD","IHE","XLV","IE00B3T34201.USD","PJP","EL","LU1066051498.USD","TRUH","VHT","BK4581","JNJ","IE00B4R5TH58.HKD","IE00BKVL7J92.USD","LU0820562030.AUD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669500261","title":"ADARx Pharmaceuticals to Sell 21.9 Million Shares at $15-$17 Each in IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669500261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669500261?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:17","pubTimestamp":1789989420,"startTime":"0","endTime":"0","summary":"ADARx Pharmaceuticals on Monday said it plans to sell nearly 21.9 million shares at between $15 and $17 apiece in its initial public offering.At the $16 midpoint of that price range, the San Diego cli","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","AGNG","FRHC","LU0320765646.SGD","LU1496350502.SGD","LU2089984988.USD","FHLC","LU1670628061.USD","REDS","SG9999001440.SGD","FTXH","XLV","LU0689626769.HKD","LU1496350171.SGD","TRUH","LU1983299246.USD","BK4585","LU2087621335.USD","ABBV","LU0289961442.SGD","IE0002141913.USD","IE00BSNM7G36.USD","BK4559","PJP","IE000BZT7R73.USD","JDOC","LU0234572021.USD","LU2237443622.USD","LU2125909247.SGD","MEDX","LU2357305700.SGD","LU2237443465.HKD","RXL","LU0203345920.USD","LU0708994859.HKD","IPOS","IXJ","LU0823416689.USD","LU1037948541.HKD","PPH","IYH","KCE","LU0943347566.SGD","LU1934455863.HKD","VHT","LU2023251221.USD","GLAM","LU0211327993.USD","LU2237443549.SGD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669502481","title":"Smart Ring Maker Oura Eyes $15.6 Billion IPO Valuation in Fall Listings Demand Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2669502481","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669502481?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:12","pubTimestamp":1789989158,"startTime":"0","endTime":"0","summary":"UPDATE 3-Oura targets $15.62 billion valuation in US IPO, setting stage for fall listingsSept 21 (Reuters)-Ourais targeting a fully diluted valuation of $15.62 billion in its US initial public...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0P8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU1069344957.HKD","MHIP","OURA","KBWB","IAI","LLYZ","MEDI","ELIL","GDOC","LU1868837300.USD","ELIS","VHT","WDNA","OZEM","LU1244550577.SGD","HRTS","FHLC","THNR","ILDR","LU0417517546.SGD","PJP","TRUH","FTXH","TMED","LU2265009873.SGD","XLV","LLYX","PPH","MEDX","GSX","CURE","IHE","JDOC","CANC","LLII","IE00B7KXQ091.USD","LLY","LU2133065610.SGD","LU1232071149.USD","IYH","LU2089283258.USD","LU0456855351.SGD","IXJ","SG9999013999.USD","IE00BZ1G4Q59.USD","LU2602419157.SGD","RXL","AGNG","LU2023250330.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669893168","title":"Immunome initiated with a Buy at Alliance Global","url":"https://stock-news.laohu8.com/highlight/detail?id=2669893168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669893168?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:05","pubTimestamp":1789988705,"startTime":"0","endTime":"0","summary":"Alliance Global initiated coverage of Immunome (IMNM) with a Buy rating and $32 price target Immunome is a biotechnology company focused on develop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunome-initiated-with-a-buy-at-alliance-global-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","DARP","FWD","XT","BK4585","BK4563","IEIH","BK4139","IMNM","BBP","LNGR","AGNG","SYNB","FHLC","IBB","BK4588","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150396","title":"Oura - Eli Lilly Interested in Purchasing up to $100 Mln; Dragoneer up to $300 Mln in IPO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150396","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150396?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:56","pubTimestamp":1789988165,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45C050:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BFTCPJ56.SGD","LU1023059063.AUD","LU0820561909.HKD","LU0210536198.USD","AGNG","LU2361044865.SGD","LU2468319806.SGD","LU2089984988.USD","LU2237443895.HKD","FHLC","LU2237438978.USD","SGXZ99366536.SGD","LU0820561818.USD","IE00BJT1NW94.SGD","MEDI","BK4516","LU0094547139.USD","LU0097036916.USD","IE0001KFT4U8.USD","SGXZ51526630.SGD","LU0106261372.USD","LU2462157665.USD","LU1232071149.USD","LU1983299246.USD","LU0640476718.USD","LU2471134879.HKD","BK4007","LU0708995401.HKD","LU0466842654.USD","LU2087625088.SGD","LU2168564495.EUR","IHE","LU1988902786.USD","IE00B4R5TH58.HKD","GDOC","LU1061106388.HKD","LU1720051017.SGD","IE00B2B36J28.USD","LU0786609619.USD","LU2357305700.SGD","LU0122379950.USD","SG9999018857.SGD","SG9999014880.SGD","LU2112291526.USD","LU1804176565.USD","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU0353189763.USD","IE00BKDWB100.SGD","IXJ","LU0823416689.USD","LU2417539215.USD","LU1323610961.USD","PPH","LU2237443382.USD","IYH","LU0316494557.USD","LU0198837287.USD","LU0689472784.USD","LU0225283273.USD","BK4588","SG9999001176.USD","LU0823434583.USD","LU0109391861.USD","LU2063271972.USD","LU0320765992.SGD","BK4599","LU0256863811.USD","LU0079474960.USD","LU1093756325.SGD","LU2237443549.SGD","LU2756315318.SGD","LU2462591350.SGD","LU2456880835.USD","IE00BK4W5M84.HKD","LU0256863902.USD","SGXZ81514606.USD","LU2271345857.HKD","LU2023250504.SGD","IE0009355771.USD","LU0345770308.USD","LU0320765059.SGD","LU0820562030.AUD","LU1291159041.SGD","LU2552382132.HKD","LU2602419157.SGD","LU2471134952.CNY","XLV","TRUH","LU0133085943.USD","LU2552382058.USD","LU0158827948.USD","LU2237443978.SGD","OZEM","LU0787776722.HKD","IE00B1XK9C88.USD","BK4581","LU1712237335.SGD","SGXZ31699556.SGD","IE00BJJMRY28.SGD","LU0964807845.USD","LU1069344957.HKD","LU2264538146.SGD","LU2491050071.SGD","LU0471298694.HKD","LU0289739699.SGD","LU2461242641.AUD","LU2023250330.USD","LU1035775433.USD","LU0174119429.USD","LU0109394709.USD","RXL","SGXZ57979304.SGD","IE0004445239.USD","IE0005OL40V9.USD","LLII","IE00B4JS1V06.HKD","VHT","IE00B1BXHZ80.USD","LU2360106947.USD","LU1267930730.SGD","LU1917777945.USD","LU0823434740.USD","LU1979441026.SGD","THNR","SG9999015952.SGD","LU2106854487.HKD","LU2168564065.EUR","IE00B775H168.HKD","LU2168564222.USD","LU2552382215.SGD","LU0456855351.SGD","LU0058720904.USD","LU2756315664.SGD","LU1868836591.USD","IE00BFSS8Q28.SGD","LU2491050154.USD","BK4533","LU1548497426.USD","IE00BKPKM429.USD","LU2265009873.SGD","LU2111349929.HKD","BK4534","LU0266013472.USD","LU0096364046.USD","LLYX","LU0432979614.USD","LU1629891620.HKD","SG9999014914.USD","LU0672654240.SGD","CURE","IE00BJJMRX11.SGD","LU0158827781.USD","LU1868837136.USD","SG9999015986.USD","LU1366192091.USD","LU1145028129.USD","IE0002141913.USD","PJP","WDNA","ELIL","JDOC","LU2213496289.HKD","LU2361044949.HKD","LU2896262040.SGD","MEDX","LU0203202063.USD","CANC","LU0114720955.EUR","LU0354030438.USD","LU2237443465.HKD","LU1064131342.USD","LU0203201768.USD","SG9999017495.SGD","SG9999014906.USD","LU2028103732.USD","LU2361045086.USD","SG9999014898.SGD","LU0417517546.SGD","LU1868836914.USD","LU1093756168.USD","LU1720051108.HKD","IE00BJJMRZ35.SGD","LU2023251221.USD","LU2089283258.USD","MHIP","ILDR","IE00BWXC8680.SGD","LU1814569148.SGD","LU0683600562.USD","LLYZ","LU0061475181.USD","LU0385154629.USD","TMED","IE00BJLML261.HKD","LU2746668461.USD","LU2746668974.SGD","SG9999013999.USD","LU1551013425.SGD","FTXH","LU0006306889.USD","LU1057294990.SGD","HRTS","LU0345770993.USD","LU2324357040.USD","LU2108987350.USD","BK4585","LU0238689110.USD","LU1623119135.USD","LU2471134523.USD","LU2750360641.GBP","LU2089284900.SGD","LU1127390331.HKD","SG9999015945.SGD","LU0882574139.USD","LU0353189680.USD","LU1868837300.USD","LU1280957306.USD","LU0234572021.USD","LU2237443622.USD","SG9999018865.SGD","LU1691799644.USD","LU2168563687.JPY","LU2750360997.AUD","LLY","ELIS","LU0889565916.HKD","LU2211815571.USD","SG9999001176.SGD","LU2491049909.HKD","LU0354030511.USD","LU2236285917.USD","IE0004445015.USD","LU0471298777.SGD","LU0943347566.SGD","LU2168564149.EUR","LU2471134796.USD","LU0882574055.USD","LU0323591593.USD","IE00BN29S564.USD","IE00B7KXQ091.USD","LU1974910355.USD","IE00BFSS7M15.SGD","LU1989771016.USD","OURA","LU1868836757.USD","SG9999015978.USD","LU1551013342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157714","title":"Japan Health Ministry Approves Merck’s Keytruda QLEX for Subcutaneous Use Across Keytruda Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157714","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669157714?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:46","pubTimestamp":1789987585,"startTime":"0","endTime":"0","summary":"Japan health ministry approves Merck’s Keytruda QLEX for subcutaneous use across Keytruda indicationsJapan’s health ministry cleared Merck’s subcutaneous Keytruda QLEX for all Keytruda indications app","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL9c8jcM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","LU1699723380.USD","VHT","LU2125909247.SGD","BK4007","LU1057294990.SGD","LU2461242641.AUD","LU1032466523.USD","IE00BSNM7G36.USD","LU1989772923.USD","LU0320765489.SGD","LU1917777945.USD","LU0861579265.USD","LU0942090050.USD","LU1974910355.USD","LU1291159041.SGD","LU1023059063.AUD","SG9999015341.SGD","LU1989771016.USD","LU1116320737.USD","LU1116320901.HKD","LU2112291526.USD","SG9999014567.USD","LU1093756168.USD","SG9999001440.SGD","LU0070302665.USD","BMED","LU2357627491.SGD","LU0124676726.USD","SG9999015358.SGD","LU0069063385.USD","BK4533","JDOC","LU1585245621.USD","LU1941712264.USD","LU0203345920.USD","LU1934455863.HKD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU0965508806.USD","LU2360032135.SGD","LU0289739699.SGD","BK4559","LU0238689110.USD","LU1923622614.USD","LU1037948541.HKD","LU2023250504.SGD","IE0002141913.USD","IE00B2B36J28.USD","GDOC","LU1037948897.HKD","LU1093756325.SGD","SG9999014559.SGD","LU0130102774.USD","LU0122379950.USD","LU2125909593.SGD","BK4550","LU0689626769.HKD","BK4534","LU1066051225.USD","SG9999001176.SGD","BK4588","LU0266013472.USD","LU0472753341.HKD","LU1066051498.USD","LU1929549753.HKD","LU0106261372.USD","LU0648001328.SGD","IE00BLSP4452.SGD","LU0965509010.AUD","LU2491049909.HKD","SG9999013999.USD","LU0098860793.USD","IE00BJJMRZ35.SGD","LU2361045086.USD","SG9999002232.USD","TRUH","IE00B1BXHZ80.USD","LU0985320562.USD","HRTS","LU1035773651.USD","SG9999001176.USD","LU2106854487.HKD","LU2089984988.USD","LU0208291251.USD","LU1061106388.HKD","PAWZ","LU0162691827.USD","SG9999014575.USD","LU0868494708.USD","LU2324357040.USD","LU2125154778.USD","LU0477156953.USD","LU0511384066.AUD","LU2023250843.SGD","FTXH","IE000M9KFDE8.USD","LU0265550946.USD","LU1941712348.USD","LU2361044949.HKD","LU0072461881.USD","LU1066051811.HKD","BK4516","LU2125154935.USD","FHLC","LU0058720904.USD","SG9999014542.SGD","IHE","IXJ","XLV","LU1983299246.USD","LU1069347547.HKD","LU0289961442.SGD","MRK","LU2361044865.SGD","LU1066053197.SGD","LU0057025933.USD","IE00BN8TJ469.HKD","RXL","LU0203347892.USD","LU0859254822.USD","LU1571399168.USD","SGXZ57979304.SGD","PPH","IE00B4R5TH58.HKD","LU2468319806.SGD","IE0009355771.USD","LU1934455277.USD","LU0130517989.USD","IE00BJT1NW94.SGD","LU0211331839.USD","IE00BLSP4239.USD","LU2491050071.SGD","LU1430594728.SGD","LU0868494617.USD","LU0265550359.USD","LU0006306889.USD","LU1989772840.SGD","LU0320765646.SGD","LU1934455194.USD","LU0965509283.SGD","LU2433249047.HKD","LU1201861249.SGD","LU0980610538.SGD","LU1162221912.USD","LU2491050154.USD","LU0965509101.SGD","IYH","IE00BBT3K403.USD","SG9999002224.SGD","LU0432979614.USD","LU0234572021.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669215775","title":"Merck’s Keytruda Qlex™ (Pembrolizumab and Berahyaluronidase Alfa-Pmph) Approved in Japan for Subcutaneous Administration for All Keytruda® (Pembrolizumab) Indications Approved in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2669215775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669215775?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:45","pubTimestamp":1789987500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA9WPNHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","LU1923622614.USD","LU2125154935.USD","RXL","LU0211331839.USD","LU1934455863.HKD","LU1699723380.USD","LU0124676726.USD","LU1116320901.HKD","LU1066051811.HKD","LU2461242641.AUD","IYH","LU1116320737.USD","GDOC","IE00BJJMRZ35.SGD","LU0072461881.USD","LU1934455277.USD","IE00BLSP4239.USD","LU1585245621.USD","BK4533","LU0266013472.USD","LU2023250843.SGD","SG9999001440.SGD","SG9999015358.SGD","LU0070302665.USD","LU0965508806.USD","BK4007","IE00BN8TJ469.HKD","BK4516","JDOC","LU0098860793.USD","LU0320765646.SGD","LU0980610538.SGD","LU2125154778.USD","LU1430594728.SGD","LU0868494617.USD","LU1201861249.SGD","SG9999013999.USD","LU1989771016.USD","LU0648001328.SGD","LU0511384066.AUD","SG9999014567.USD","LU1571399168.USD","BK4559","MRK","BMED","LU2361045086.USD","LU2357627491.SGD","IE00B4R5TH58.HKD","HRTS","LU0965509101.SGD","SG9999015341.SGD","BK4588","LU0861579265.USD","LU1066051225.USD","PPH","LU2112291526.USD","LU0203345920.USD","LU0320765489.SGD","LU1093756168.USD","LU1162221912.USD","LU1032466523.USD","LU0289961442.SGD","TRUH","LU2491049909.HKD","LU0965509010.AUD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU0058720904.USD","BK4550","LU0234572021.USD","FHLC","LU0122379950.USD","LU0432979614.USD","LU2324357040.USD","SG9999014575.USD","LU2491050154.USD","IE00BBT3K403.USD","LU2089984988.USD","LU0965509283.SGD","LU1974910355.USD","LU0130517989.USD","IE00B1BXHZ80.USD","LU2468319806.SGD","LU0106261372.USD","LU1093756325.SGD","LU2361044949.HKD","LU1066051498.USD","LU0208291251.USD","LU2023250504.SGD","LU1929549753.HKD","SG9999014542.SGD","SG9999002232.USD","LU2360032135.SGD","LU0289739343.SGD","FTXH","IE00BLSP4452.SGD","LU1037948541.HKD","LU1057294990.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0057025933.USD","LU0289739699.SGD","LU1061106388.HKD","PAWZ","LU1066053197.SGD","LU0069063385.USD","LU0689626769.HKD","LU2125909247.SGD","LU1941712348.USD","LU1989772840.SGD","LU2491050071.SGD","SG9999001176.SGD","LU0162691827.USD","LU1934455194.USD","LU0238689110.USD","LU1035773651.USD","LU0265550359.USD","IE0009355771.USD","LU1989772923.USD","LU2106854487.HKD","LU0265550946.USD","LU0942090050.USD","LU1037948897.HKD","XLV","VHT","LU0203347892.USD","BK4585","LU2361044865.SGD","LU0006306889.USD","IHE","LU0859254822.USD","LU1023059063.AUD","SG9999014559.SGD","IE00BJT1NW94.SGD","LU0130102774.USD","SG9999001176.USD","SG9999002224.SGD","IE00BSNM7G36.USD","LU0477156953.USD","BK4534","LU2433249047.HKD","LU0868494708.USD","LU1941712264.USD","LU1917777945.USD","LU1069347547.HKD","LU1983299246.USD","LU0985320562.USD","LU0472753341.HKD","LU2125909593.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669157222","title":"Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2669157222","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669157222?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:44","pubTimestamp":1789987466,"startTime":"0","endTime":"0","summary":"Novo says its next-gen obesity drug tops Lilly rival in late-stage studySept 21 (Reuters)-Novo NordiskNOVOb.COsaid on Monday its next-generation experimental drug had achieved an estimated average weight loss of 12.4% in a late-stage trial and that it was superior to Eli Lilly'sLLY.Ndrug.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJJMRX11.SGD","FTXH","LU0289739699.SGD","LU0316494557.USD","IE0005OL40V9.USD","LU1232071149.USD","LU1323610961.USD","BK4599","IE0002141913.USD","LU1145028129.USD","LU1035775433.USD","SG9999014898.SGD","LU2471134523.USD","LU2552382058.USD","LU0820562030.AUD","MHIP","LU0198837287.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU0106261372.USD","LLYX","LU2491050154.USD","BK4588","CANC","LU1989771016.USD","LU2112291526.USD","AGNG","LU2271345857.HKD","LU0154236417.USD","LU2023250504.SGD","LU0323591593.USD","LU0353189763.USD","LU1917777945.USD","LU2237443465.HKD","LU2357305700.SGD","LU0345770308.USD","LU0823434740.USD","LU1057294990.SGD","LU1623119135.USD","LU0158827781.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","LU2213496289.HKD","SG9999015952.SGD","LU1551013342.USD","LU0061475181.USD","LU0058720904.USD","SGXZ81514606.USD","IYH","LU0234572021.USD","ELIS","LU0006306889.USD","LU0882574055.USD","LU0109391861.USD","LU2089283258.USD","IE00BKVL7J92.USD","LU0097036916.USD","LU0708995401.HKD","LU2756315318.SGD","LU2089984988.USD","SG9999015978.USD","LU2111349929.HKD","LU1548497426.USD","LU2746668461.USD","LU0466842654.USD","LU2750360997.AUD","LU0210536198.USD","MEDX","LU2063271972.USD","SG9999013999.USD","LU0943347566.SGD","IHE","IE00BJLML261.HKD","IE00BFSS8Q28.SGD","LU0882574139.USD","LU2471134796.USD","LU0640476718.USD","LU0122379950.USD","LU0432979614.USD","LU0823416689.USD","LU1814569148.SGD","LU0225283273.USD","LU1868836914.USD","LU2023250330.USD","LU1629891620.HKD","LU2265009873.SGD","LU0079474960.USD","LU1280957306.USD","GB00BDT5M118.USD","LU2168564222.USD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999014906.USD","LU2237443978.SGD","JDOC","LU2462591350.SGD","LU0964807845.USD","LU2461242641.AUD","LU2471134879.HKD","LU2552382215.SGD","LU2552382132.HKD","LU0203202063.USD","LU0345770993.USD","NVOH","LU1291159041.SGD","LU2491050071.SGD","LLY","LU1267930730.SGD","LLII","SG9999014914.USD","TRUH","LU1127390331.HKD","VHT","LU1868837136.USD","LU2023251221.USD","SG9999015986.USD","LU0256863902.USD","SGXZ51526630.SGD","IE00B1XK9C88.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2236285917.USD","LU2237443895.HKD","LU2361044949.HKD","LU0672654240.SGD","LU1366192091.USD","IE00BJJMRY28.SGD","LU0158827948.USD","SG9999014880.SGD","LU2089284900.SGD","LU1023059063.AUD","NVOC","ELIL","LU2324357040.USD","LU0266013472.USD","SGXZ31699556.SGD","LU2237443382.USD","PJP","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU0094547139.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2468319806.SGD","LU1988902786.USD","LU2360106947.USD","TMED","NVOX","LU2361045086.USD","HRTS","LU1712237335.SGD","SG9999018857.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU1868836591.USD","LU2896262040.SGD","LU1868836757.USD","LU0417517546.SGD","LU0823434583.USD","LU2168564149.EUR","LU2264538146.SGD","IE0009355771.USD","LU0385154629.USD","LU2417539215.USD","LU2237443549.SGD","LU2756315664.SGD","IE00BKDWB100.SGD","RXL","IE0004445015.USD","LU0133085943.USD","LU1979441026.SGD","LU2106854487.HKD","IE00BK4W5L77.USD","LU0471298777.SGD","IE00B7KXQ091.USD","CURE","ILDR","LU0689472784.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU1551013425.SGD","IE0001KFT4U8.USD","WDNA","LU0203201768.USD","LU2602419157.SGD","LU0683600562.USD","LU2168564495.EUR","IE00BN29S564.USD","LU0114720955.EUR","LU0320765992.SGD","SG9999018865.SGD","LU1064131342.USD","LU1691799644.USD","LU0109394709.USD","FHLC","SG9999017495.SGD","THNR","MEDI","IE00B4JS1V06.HKD","LU0320765059.SGD","BK4534","IE00BWXC8680.SGD","LU1983299246.USD","LU2237438978.USD","LU2746668974.SGD","LU1720051108.HKD","LU0787776722.HKD","OZEM","LLYZ","LU1061106388.HKD","LU0353189680.USD","LU0820561909.HKD","BK4532","GDOC","BK4581","LU0456855351.SGD","LU1974910355.USD","LU1804176565.USD","LU2491049909.HKD","IXJ","LU0174119429.USD","IE00BK4W5M84.HKD","IE00BZ1G4Q59.USD","SG9999001176.USD","LU2456880835.USD","IE00B775H168.HKD","LU1868837300.USD","LU2750360641.GBP","LU2462157665.USD","NVO","LU0820561818.USD","LU2237443622.USD","LU2471134952.CNY","SG9999015945.SGD","LU1093756168.USD","LU0786609619.USD","LU2361044865.SGD","PPH","BK4533","LU1069344957.HKD","LU2087625088.SGD","SGXZ99366536.SGD","XLV","LU2028103732.USD","LU0354030511.USD","LU2108987350.USD","IE0004445239.USD","LU0471298694.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669315794","title":"Drug Developer ADARx Seeks $1.74 Billion Valuation in US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2669315794","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669315794?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:32","pubTimestamp":1789986739,"startTime":"0","endTime":"0","summary":"UPDATE 3-Drug developer ADARx seeks $1.74 billion valuation in US IPOSept 21 (Reuters)-ADARx Pharmaceuticals, which develops RNA-based drugs for rare diseases, said on Monday that it was targeting a v","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","MEDX","IE0004445239.USD","LU2357627491.SGD","LU0417517546.SGD","LU2089283258.USD","LU1720051017.SGD","BK4581","IYH","JDOC","VHT","LU2433249047.HKD","FHLC","IE00B2B36J28.USD","TRUH","LU0289961442.SGD","IXJ","SG9999003800.SGD","PJP","PPH","LU0256863902.USD","LU0985320562.USD","IE00BGHQF631.EUR","BK4559","BK4585","LU0708994859.HKD","LU2129689431.USD","BK4566","RXL","ABBV","LU2237443978.SGD","LU1989772923.USD","LU2237443465.HKD","GLAM","FTXH","IE00BVYPNV92.GBP","XLV","ETRA","LU2347655156.SGD","LU1023059063.AUD","LU0689626769.HKD","LU1236620750.USD","LU1093756168.USD","LU2133065610.SGD","AGNG","LU0868494708.USD","SG9999015978.USD","LU2237443549.SGD","IE000BZT7R73.USD","IE00BDGV0183.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669087135","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669087135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669087135?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:01","pubTimestamp":1789952478,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK), Envista Holdings (NVST) and Ultragenyx Pha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-envista-holdings-nvst-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-envista-holdings-nvst-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRK","BK4516","LU1116320901.HKD","BK4585","LU1037948897.HKD","LU0265550946.USD","LU2357627491.SGD","LU2361045086.USD","LU1934455863.HKD","BK4588","LU0320765646.SGD","LU0432979614.USD","LU0477156797.USD","LU0965508806.USD","PPH","LU0266013472.USD","LU1983299246.USD","LU1061106388.HKD","LU1066051811.HKD","LU2089984988.USD","IE00BLSP4452.SGD","LU0823416689.USD","LU0965509010.AUD","LU2112291526.USD","LU1057294990.SGD","BMED","LU0265550359.USD","FHLC","SG9999014567.USD","TRUH","LU0057025933.USD","LU0289739699.SGD","LU0477156953.USD","LU1941712264.USD","IYH","LU0868494617.USD","LU2106854487.HKD","SG9999013999.USD","RARE","FTXH","LU0942090050.USD","BK4139","NVST","LU1923622614.USD","LU0289961442.SGD","BK4559","LU1917777945.USD","LU2360032135.SGD","LU1032466523.USD","LU1699723380.USD","LU2125154778.USD","SG9999015341.SGD","JDOC","LU1201861249.SGD","LU1093756325.SGD","LU0234572021.USD","IE00BBT3K403.USD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE0034390439.USD","IE00B2B36J28.USD","LU1066051225.USD","LU2491049909.HKD","LU0472753341.HKD","LU2433249047.HKD","RXL","LU1093756168.USD","IE00BLSP4239.USD","LU0985320562.USD","SGXZ57979304.SGD","LU0069063385.USD","LU1066053197.SGD","IE0009355771.USD","LU2491050071.SGD","GDOC","BK4550","LU1989771016.USD","LU1430594728.SGD","LU2125909247.SGD","LU2023250843.SGD","LU0006306889.USD","IE00BSNM7G36.USD","LU1571399168.USD","IE000M9KFDE8.USD","SG9999001176.SGD","LU0868494708.USD","LU1162221912.USD","LU2461242641.AUD","LU1989772923.USD","BK4534","LU1023059063.AUD","LU0511384066.AUD","LU0648000940.SGD","LU0965509101.SGD","LU1989772840.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","SG9999002232.USD","SG9999014542.SGD","LU2468319806.SGD","PAWZ","SG9999014575.USD","LU1934455194.USD","LU2125909593.SGD","IXJ","IE00BFTCPJ56.SGD","LU1941712348.USD","LU1934455277.USD","LU0098860793.USD","LU1066051498.USD","SG9999015358.SGD","LU2324357040.USD","LU0106261372.USD","LU2125154935.USD","BK4533","LU0203347892.USD","LU0980610538.SGD","SG9999001176.USD","LU1201861165.SGD","IHE","LU0058720904.USD","LU0124676726.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","LU0859254822.USD","LU0861579265.USD","LU0130103400.USD","VHT","IE00B19Z6F94.USD","LU0320765489.SGD","SG9999014559.SGD","LU1037948541.HKD","BK4007","LU0072461881.USD","LU0211331839.USD","LU1291159041.SGD","SG9999001440.SGD","SG9999002224.SGD","LU0689626769.HKD","LU0130102774.USD","LU0122379950.USD","LU0648001328.SGD","LU0130517989.USD","LU1974910355.USD","LU0070302665.USD","LU0238689110.USD","LU0289739343.SGD","LU1929549753.HKD","BK4082","HRTS","IE0002141913.USD","LU0130518102.USD","LU0162691827.USD","LU0203345920.USD","LU1069347547.HKD","LU1035773651.USD","LU2023250504.SGD","LU1585245621.USD","LU2491050154.USD","LU2361044949.HKD","LU1116320737.USD","IE00BN8TJ469.HKD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669133990","title":"Prescient Therapeutics Requests Trading Halt Ahead of Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669133990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669133990?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:07","pubTimestamp":1789949265,"startTime":"0","endTime":"0","summary":"The latest update is out from Prescient Therapeutics Limited ( ($AU:PTX) ). Prescient Therapeutics Limited, an ASX-listed Australian biotechnology ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-requests-trading-halt-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-requests-trading-halt-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","FWD","IBB","RSPH","BK4539","IEIH","BBP","DARP","JDOC","AGNG","XT","LNGR","BK4585","BK4007","LENZ","FHLC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668184620","title":"Eli Lilly, Novo sued over risk of sudden vision loss, WSJ reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2668184620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668184620?lang=en_us&edition=fundamental","pubTime":"2026-09-20 22:55","pubTimestamp":1789916110,"startTime":"0","endTime":"0","summary":"Dozens of people are suing Novo Nordisk (NVO), claiming its weight-loss and diabetes drugs Wegovey and Ozempic caused their nonarteritic anterior i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-novo-sued-over-risk-of-sudden-vision-loss-wsj-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-novo-sued-over-risk-of-sudden-vision-loss-wsj-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMED","IE0004445239.USD","IE0005OL40V9.USD","SG9999014880.SGD","LU0786609619.USD","ELIL","LU1868836591.USD","ILDR","LU0058720904.USD","LU0353189680.USD","LU0787776722.HKD","NVO","LU1280957306.USD","LU1366192091.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU2168564149.EUR","BK4581","LU0889565916.HKD","GDOC","LU2028103732.USD","IE00BKVL7J92.USD","TRUH","LU1804176565.USD","LU2237438978.USD","LU0203202063.USD","LU0174119429.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B775H168.HKD","LU0823416689.USD","LU2236285917.USD","IE00BJJMRY28.SGD","LU2361045086.USD","LU2491050071.SGD","SG9999014906.USD","BK4533","SGXZ51526630.SGD","LU1057294990.SGD","LU0882574055.USD","LU2417539215.USD","LU0471298694.HKD","LU2108987350.USD","LU2756315318.SGD","LU2089283258.USD","LU2361044949.HKD","LU2471134952.CNY","LU0689472784.USD","IE00BWXC8680.SGD","BK4516","SG9999017495.SGD","BK4534","LU2168564065.EUR","SG9999015978.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU2023250504.SGD","LU1623119135.USD","SG9999001176.SGD","LU1127390331.HKD","LU1232071149.USD","LU0708995401.HKD","LU2552382215.SGD","LU1988902786.USD","LU2265009873.SGD","NVOH","LU2361044865.SGD","LU2112291526.USD","LU0109394709.USD","LU0354030511.USD","LU1267930730.SGD","LU0061475181.USD","MEDX","LU0096364046.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2746668461.USD","LU0154236417.USD","LU1548497426.USD","LU1989771016.USD","LU0225283273.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU0079474960.USD","LU1720051017.SGD","LU2461242641.AUD","IXJ","IE0009355771.USD","LU0158827948.USD","VHT","LU0256863902.USD","FHLC","FTXH","LU0672654240.SGD","LU0097036916.USD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2360106947.USD","BK4007","LU0114720955.EUR","GB00BDT5M118.USD","LU0133085943.USD","LU0345770308.USD","LU2168564222.USD","LU2462157665.USD","LU2750360997.AUD","LU0106261372.USD","LU0266013472.USD","LU2111349929.HKD","SG9999013999.USD","LU1023059063.AUD","SG9999018865.SGD","LU2552382132.HKD","LU0234572021.USD","LU2462591350.SGD","IE00BFTCPJ56.SGD","OZEM","LU2168563687.JPY","LU2237443382.USD","SG9999014898.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU0964807845.USD","LU1093756325.SGD","LU2264538146.SGD","LU0210536198.USD","PPH","LU2023250330.USD","IHE","LU2237443465.HKD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","JDOC","AGNG","IE0001KFT4U8.USD","LU2468319806.SGD","LU0683600562.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2089984988.USD","LU0256863811.USD","LU1868837300.USD","LU2168564495.EUR","IE00BK4W5L77.USD","NVOX","SG9999014914.USD","LU0820561909.HKD","LU2491049909.HKD","LU1868836914.USD","LU2211815571.USD","LU2213496289.HKD","LU1323610961.USD","SG9999018857.SGD","SGXZ57979304.SGD","LLYZ","LU0417517546.SGD","CANC","THNR","SG9999015945.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","LU2471134796.USD","CURE","LU1629891620.HKD","LU2602419157.SGD","BK4599","LU0323591593.USD","MEDI","LLII","LU1974910355.USD","LU1064131342.USD","LU1035775433.USD","LU1712237335.SGD","LU0823434583.USD","IYH","LU0320765992.SGD","LU0432979614.USD","IE00BKDWB100.SGD","LU2357305700.SGD","ELIS","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","LLY","LU1814569148.SGD","LU2750360641.GBP","LU1691799644.USD","LU2237443895.HKD","WDNA","PJP","LU0122379950.USD","LU0471298777.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0385154629.USD","LU0353189763.USD","LU0456855351.SGD","LU2456880835.USD","BK4585","LU1145028129.USD","LU1868837136.USD","LU1551013425.SGD","LU1093756168.USD","LU2324357040.USD","LU2552382058.USD","LU2237443549.SGD","HRTS","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","BK4532","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU1551013342.USD","LU0238689110.USD","LU2491050154.USD","BK4588","LU0109391861.USD","LU1979441026.SGD","LU0198837287.USD","LU2106854487.HKD","IE0004445015.USD","NVOC","LU0006306889.USD","LU0820561818.USD","LU0820562030.AUD","IE00BN29S564.USD","LU1917777945.USD","MHIP","LU0158827781.USD","LU0640476718.USD","LU2237443978.SGD","LU0354030438.USD","LU0882574139.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE00BK4W5M84.HKD","XLV","LU0316494557.USD","LLYX","LU2237443622.USD","SG9999015986.USD","LU2063271972.USD","LU0345770993.USD","LU0094547139.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668058879","title":"Lilly, Novo face lawsuits over GLP-1 vision loss risk, WSJ says","url":"https://stock-news.laohu8.com/highlight/detail?id=2668058879","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668058879?lang=en_us&edition=fundamental","pubTime":"2026-09-19 21:10","pubTimestamp":1789823412,"startTime":"0","endTime":"0","summary":"Some emerging scientific research points to an increased risk for GLP-1 patients to develop nonarteritic anterior ischemic optic neuropathy, or vis...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lilly-novo-face-lawsuits-over-glp-1-vision-loss-risk-wsj-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lilly-novo-face-lawsuits-over-glp-1-vision-loss-risk-wsj-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":17,"totalSize":338,"code":"91000000","status":"200"}]}}